statements

Jupiter Bioscience Ltd

NSE: JUPITER

Sector: Chemicals

Industry Group: Chemicals & Petrochemicals

Industry: Commodity Chemicals

4.15-0.1 (-2.35%)

11 Jan, 12:00 AM

Overview Analysis Statements

Technicals Forecast Peers Resources News

Income Statement

Abridged

Understanding Income Statement

Jupiter Bioscience Ltd income statement covering revenue, operating profit, EBITDA, PAT and EPS across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2003 Mar 31	2004 Mar 31	2005 Mar 31	C 2006 Mar 31	C 2007 Mar 31	2008 Mar 31	2009 Mar 31	2010 Mar 31	2011 Mar 31
	C 2003 Mar 31	2004 Mar 31	2005 Mar 31	C 2006 Mar 31	C 2007 Mar 31	2008 Mar 31	2009 Mar 31	2010 Mar 31	2011 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Total Revenue	62.44	70.30	80.31	91.46	121.43	154.55	177.52	232.55	331.26
Cost of Operating Revenue	47.27	61.52	66.94	68.51	69.90	85.22	96.67	122.35	193.71
Gross Profit	15.16	8.78	13.37	22.95	51.53	69.33	80.85	110.19	137.56
Gross Margin	24.3	12.5	16.6	25.1	42.4	44.9	45.5	47.4	41.5
Total Operating Expenses	42.69	47.86	54.06	61.13	86.21	108.50	122.75	157.49	243.78
Operating Profit	19.74	22.44	26.25	30.33	35.22	46.05	54.77	75.06	87.48
Operating Margin	31.6	31.9	32.7	33.2	29.0	29.8	30.9	32.3	26.4
Financing Income/(Expense) - Net	-2.51	-4.04	-5.60	-7.16	-8.14	-11.83	-18.65	-26.11	-29.18
Profit before Taxes	17.39	18.55	20.83	23.35	27.06	34.46	37.75	49.07	58.28
Income Taxes	2.60	2.67	5.91	4.97	6.83	4.72	4.71	6.59	6.92
Profit after Tax	14.79	15.88	14.92	18.38	20.23	29.74	33.04	42.48	51.36
PAT Margin	23.7	22.6	18.6	20.1	16.7	19.2	18.6	18.3	15.5
EPS - Basic - ex Extraordinary Items	16.56	17.92	16.83	20.74	20.51	19.66	20.48	23.30	7.96
EPS - Diluted - ex Extraordinary Items	16.56	17.92	16.83	20.74	20.49	19.66	19.66	23.22	7.96
EBIT	19.74	22.44	26.25	30.33	35.22	46.05	54.77	75.06	87.48
EBITDA	25.28	29.88	36.06	42.31	51.57	68.46	87.93	119.43	146.24
EBITDA Margin	40.5	42.5	44.9	46.3	42.5	44.3	49.5	51.4	44.1

Balance Sheet

Abridged

Understanding Balance Sheet

Jupiter Bioscience Ltd balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	C 2003 Mar 31	2004 Mar 31	2005 Mar 31	2006 Mar 31	2007 Mar 31	2008 Mar 31	2009 Mar 31	2010 Mar 31	2011 Mar 31
	C 2003 Mar 31	2004 Mar 31	2005 Mar 31	2006 Mar 31	2007 Mar 31	2008 Mar 31	2009 Mar 31	2010 Mar 31	2011 Mar 31
Source:	AR	AR	AR	AR	AR	AR	AR	AR	AR
Total Current Assets	35	50	39	52	86	116	138	169	209
Long-Term Investments	2	22	2	1	1	1	10	18	301
Property Plant & Equipment - Net	65	85	107	137	224	364	463	624	772
Total Non-Current Assets	83	139	158	200	285	423	532	704	1,155
Total Assets	118	189	197	252	371	539	670	873	1,364
Total Current Liabilities	7	8	11	16	21	23	21	19	35
Long Term Debt	36	72	84	114	173	193	294	420	448
Total Non-Current Liabilities	38	73	85	116	180	207	314	445	475
Total Liabilities	44	82	96	132	200	230	335	465	510
Total Shareholders' Equity	74	108	100	120	171	309	335	408	854
Total Equity	74	108	100	120	171	309	335	408	854
Total Liabilities & Equity	118	189	197	252	371	539	670	873	1,364

Cash Flow

Abridged

Understanding Cash Flow Statement

Jupiter Bioscience Ltd cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2003 Mar 31	2004 Mar 31	2005 Mar 31	2006 Mar 31	2007 Mar 31	2008 Mar 31	2009 Mar 31	2010 Mar 31	2011 Mar 31
	2003 Mar 31	2004 Mar 31	2005 Mar 31	2006 Mar 31	2007 Mar 31	2008 Mar 31	2009 Mar 31	2010 Mar 31	2011 Mar 31
Period length: Source:	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	16.62	17.90	27.20	32.74	39.31	56.36	68.58	88.57	111.64
Working Capital - Increase/(Decrease)	-2.01	-7.53	5.56	-8.24	-29.70	-20.43	-19.11	-22.58	-23.29
Net CF from Operating Activities	14.62	10.37	32.75	24.50	9.62	35.93	49.47	65.99	88.36
Capital Expenditures - Net	23.76	23.42	28.32	18.13	64.27	119.83	109.13	134.98	164.31
Net CF from Investing Activities	-35.10	-64.60	-47.33	-56.81	-104.69	-164.08	-143.91	-220.18	-514.57
Dividends Paid - Cash - Total	-	-	1.99	2.22	2.22	3.63	3.23	3.23	6.24
Stock - Issuance/(Retirement) - Net	0.05	19.95	-	4.14	32.59	112.54	-9.34	36.75	403.63
Debt - LT & ST - Issuance/(Retirement) - Total	17.85	35.78	11.63	30.68	58.11	20.63	100.69	126.61	27.06
Net Cash Flow from Financing Activities	17.90	55.73	8.78	32.76	96.13	128.06	93.63	159.05	424.06
Free Cash Flow to Equity	8.71	22.74	16.06	37.05	3.46	-63.27	41.02	57.62	-48.90
Free Operating CF net dividend	-9.15	-13.05	2.44	4.15	-56.87	-87.53	-62.89	-72.21	-82.20
Free Operating CF	-9.15	-13.05	4.43	6.37	-54.65	-83.90	-59.66	-68.99	-75.96

Business Segment Analysis

Jupiter Bioscience Ltd business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

We don't have enough data to show business segment analysis for Jupiter Bioscience Ltd

Regional Segment Analysis

FY End:

Mar 11

Jupiter Bioscience Ltd geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (98.9%)₹ 327.64 CrPakistan (0.3%)₹ 1.09 CrGermany (0.3%)₹ 0.87 CrSwitzerland (0.2%)₹ 0.74 CrFrance (0.1%)₹ 0.28 CrLatin American (0.1%)₹ 0.26 CrIran (0.1%)₹ 0.22 CrKenya (0.0%)₹ 0.07 CrUnited Kingdom (0.0%)₹ 0.03 CrGhana (0.0%)₹ 0.02 CrBangladesh (0.0%)₹ 0.02 CrJapan (0.0%)₹ 0.02 CrBelgium (0.0%)₹ 0.01 Cr

Historical Segment Analysis

Track how Jupiter Bioscience Ltd segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Sales

Business

Regional

Business

We don't have enough data to show the Capex for Jupiter Bioscience Ltd.

Frequently Asked Questions

What is the revenue of Jupiter Bioscience Ltd?

The latest trailing twelve month revenue of Jupiter Bioscience Ltd is -. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Jupiter Bioscience Ltd?

The latest trailing twelve month net profit (PAT) of Jupiter Bioscience Ltd is -. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Jupiter Bioscience Ltd?

The operating margin of Jupiter Bioscience Ltd is -. Detailed EBITDA history is available in the Income Statement section of the Statements tab.

What is the EPS of Jupiter Bioscience Ltd?

The trailing twelve month Earnings Per Share (EPS) of Jupiter Bioscience Ltd is -. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Jupiter Bioscience Ltd?

The debt-to-equity ratio of Jupiter Bioscience Ltd stands at -. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Jupiter Bioscience Ltd?

The book value per share of Jupiter Bioscience Ltd is available in the Balance Sheet section of the Statements tab.

What is the cash flow from operations of Jupiter Bioscience Ltd?

Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Jupiter Bioscience Ltd report consolidated or standalone financials?

Jupiter Bioscience Ltd reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.